Accolade, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2023
October 04, 2023 at 04:05 pm EDT
Share
Accolade, Inc. reported earnings results for the second quarter and six months ended August 31, 2023. For the second quarter, the company reported sales was USD 96.86 million compared to USD 87.64 million a year ago. Net loss was USD 32.83 million compared to USD 46.52 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 0.66 a year ago.
For the six months, sales was USD 190.09 million compared to USD 173.17 million a year ago. Net loss was USD 71.23 million compared to USD 389.35 million a year ago. Basic loss per share from continuing operations was USD 0.96 compared to USD 5.54 a year ago.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
